查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1360320

透皮皮肤贴片市场（产品类型：储存库、药物黏合剂、基质、微针等；销售类型：处方药和非处方药 [OTC]）－全球产业分析、规模、份额、成长、趋势，以及预测，2023-2031

Transdermal Skin Patches Market (Product Type: Reservoir, Drug-in-Adhesive, Matrix, Microneedle, and Others; and Sales Type: Prescription and Over-the-Counter [OTC]) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 186 Pages | 商品交期: 2-10个工作天内

价格

透皮皮肤贴片市场 - 报告范围

TMR 关于全球透皮皮肤贴片市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球透皮皮肤贴片的收入2017-2031年期间的市场，考虑2023年为基准年，2031年为预测年。该报告也提供了2023年至2031年全球透皮皮肤贴片市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解透皮皮肤贴片市场。

市场概况
2023年市场价值 77 亿美元
2031 年市场价值 115 亿美元
复合年增长率 4.6%

该报告深入研究了全球透皮皮肤贴片市场的竞争格局。已经确定了全球透皮皮肤贴片市场的主要参与者，并对其中每位参与者的各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球透皮皮肤贴片市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2017 - 2031 年全球市场分析与预测

第 5 章：关键见解

  • 按地区/全球分類的监管情景
  • 全球主要国家的疾病盛行率和发生率
  • 管道分析
  • 主要产品/品牌分析
  • COVID-19 对产业的影响

第 6 章：全球市场分析与预测：依产品类型

  • 简介与定义
  • 主要发现/进展
  • 2017 - 2031 年按产品类型分類的市场价值预测
    • 水库
    • 黏合剂中的药物
      • 单层
      • 多层
    • 微型针
    • 矩阵
    • 其他（蒸气等）
  • 按产品类型分類的市场吸引力

第 7 章：全球市场分析与预测：按应用分类

  • 简介与定义
  • 主要发现/进展
  • 2017 - 2031 年按应用的市场价值预测
    • 疼痛管理
    • 荷尔蒙失调
    • 减少吸烟和戒烟援助
    • 神经系统疾病
    • 心血管疾病
    • 其他（晕车、膀胱过动症等）
  • 按应用的市场吸引力

第 8 章：全球市场分析与预测：依销售类型

  • 简介与定义
  • 主要发现/进展
  • 2017 - 2031 年按销售类型分類的市场价值预测
    • 处方
    • 场外交易 (OTC)
  • 按销售类型分類的市场吸引力

第 9 章：全球市场分析与预测：按配销通路

  • 简介与定义
  • 主要发现/进展
  • 2017 - 2031 年按配销通路分類的市场价值预测
    • 医院药房
    • 零售药局
    • 网路药局
  • 按配销通路分類的市场吸引力

第 10 章：全球市场分析与预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 按国家/地区分類的市场吸引力

第 11 章：北美市场分析与预测

第 12 章：欧洲市场分析与预测

第 13 章：亚太市场分析与预测

第 14 章：拉丁美洲市场分析与预测

第 15 章：中东和非洲市场分析与预测

第16章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 公司市占率分析 (2022)
  • 公司简介
    • Hisamitsu Pharmaceutical Co., Inc.
    • Viatris Inc.
    • Nitto Denko Corporation
    • Novartis AG
    • Luye Pharma Group
    • Teikoku Pharma
    • Samyang Holdings Corporation
    • Gedeon Richter PLC
    • AdhexPharma
    • Sparsha Pharma International Pvt. Ltd.
Product Code: TMRGL2245

Transdermal Skin Patches Market - Scope of Report

TMR's report on the global transdermal skin patches market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global transdermal skin patches market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global transdermal skin patches market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the transdermal skin patches market.

Market Snapshot
Market Value in 2023US$ 7.7 Bn
Market Value in 2031US$ 11.5 Bn
CAGR4.6%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global transdermal skin patches market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global transdermal skin patches market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global transdermal skin patches market.

The report delves into the competitive landscape of the global transdermal skin patches market. Key players operating in the global transdermal skin patches market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global transdermal skin patches market profiled in this report.

Key Questions Answered in Global Transdermal Skin Patches Market Report:

  • What is the sales/revenue generated by transdermal skin patches across all regions during the forecast period?
  • What are the opportunities in the global transdermal skin patches market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Transdermal Skin Patches Market - Research Objectives and Research Approach

The comprehensive report on the global transdermal skin patches market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global transdermal skin patches market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global transdermal skin patches market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Transdermal Skin Patches Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Transdermal Skin Patches Market Analysis and Forecast, 2017 - 2031
    • 4.4.1. Market Revenue Projection (US$ Bn)

5. Key Insights

  • 5.1. Regulatory Scenario by Region/Globally
  • 5.2. Disease Prevalence & Incidence Rate Globally with Key Countries
  • 5.3. Pipeline Analysis
  • 5.4. Key Product/brand Analysis
  • 5.5. COVID-19 Impact on the Industry

6. Global Transdermal Skin Patches Market Analysis and Forecast, By Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product Type, 2017 - 2031
    • 6.3.1. Reservoir
    • 6.3.2. Drug-in-Adhesive
      • 6.3.2.1. Single Layer
      • 6.3.2.2. Multilayer
    • 6.3.3. Microneedle
    • 6.3.4. Matrix
    • 6.3.5. Others (Vapor, etc.)
  • 6.4. Market Attractiveness By Product Type

7. Global Transdermal Skin Patches Market Analysis and Forecast, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2017 - 2031
    • 7.3.1. Pain Management
    • 7.3.2. Hormonal Disorders
    • 7.3.3. Smoking Reduction and Cessation Aid
    • 7.3.4. Neurological Disorders
    • 7.3.5. Cardiovascular Disorders
    • 7.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
  • 7.4. Market Attractiveness By Application

8. Global Transdermal Skin Patches Market Analysis and Forecast, By Sales Type

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Sales Type, 2017 - 2031
    • 8.3.1. Prescription
    • 8.3.2. Over-the-Counter (OTC)
  • 8.4. Market Attractiveness By Sales Type

9. Global Transdermal Skin Patches Market Analysis and Forecast, By Distribution Channel

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By Distribution Channel, 2017 - 2031
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Pharmacies
  • 9.4. Market Attractiveness By Distribution Channel

10. Global Transdermal Skin Patches Market Analysis and Forecast, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Transdermal Skin Patches Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product Type, 2017 - 2031
    • 11.2.1. Reservoir
    • 11.2.2. Drug-in-Adhesive
      • 11.2.2.1. Single Layer
      • 11.2.2.2. Multilayer
    • 11.2.3. Microneedle
    • 11.2.4. Matrix
    • 11.2.5. Others (Vapor, etc.)
  • 11.3. Market Value Forecast By Application, 2017 - 2031
    • 11.3.1. Pain Management
    • 11.3.2. Hormonal Disorders
    • 11.3.3. Smoking Reduction and Cessation Aid
    • 11.3.4. Neurological Disorders
    • 11.3.5. Cardiovascular Disorders
    • 11.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
  • 11.4. Market Value Forecast By Sales Type, 2017 - 2031
    • 11.4.1. Prescription
    • 11.4.2. Over-the-Counter (OTC)
  • 11.5. Market Value Forecast By Distribution Channel, 2017 - 2031
    • 11.5.1. Hospital Pharmacies
    • 11.5.2. Retail Pharmacies
    • 11.5.3. Online Pharmacies
  • 11.6. Market Value Forecast By Country, 2017 - 2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Application
    • 11.7.3. By Sales Type
    • 11.7.4. By Distribution Channel
    • 11.7.5. By Country

12. Europe Transdermal Skin Patches Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product Type, 2017 - 2031
    • 12.2.1. Reservoir
    • 12.2.2. Drug-in-Adhesive
      • 12.2.2.1. Single Layer
      • 12.2.2.2. Multilayer
    • 12.2.3. Microneedle
    • 12.2.4. Matrix
    • 12.2.5. Others (Vapor, etc.)
  • 12.3. Market Value Forecast By Application, 2017 - 2031
    • 12.3.1. Pain Management
    • 12.3.2. Hormonal Disorders
    • 12.3.3. Smoking Reduction and Cessation Aid
    • 12.3.4. Neurological Disorders
    • 12.3.5. Cardiovascular Disorders
    • 12.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
  • 12.4. Market Value Forecast By Sales Type, 2017 - 2031
    • 12.4.1. Prescription
    • 12.4.2. Over-the-Counter (OTC)
  • 12.5. Market Value Forecast By Distribution Channel, 2017 - 2031
    • 12.5.1. Hospital Pharmacies
    • 12.5.2. Retail Pharmacies
    • 12.5.3. Online Pharmacies
  • 12.6. Market Value Forecast By Country, 2017 - 2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Application
    • 12.7.3. By Sales Type
    • 12.7.4. By Distribution Channel
    • 12.7.5. By Country

13. Asia Pacific Transdermal Skin Patches Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product Type, 2017 - 2031
    • 13.2.1. Reservoir
    • 13.2.2. Drug-in-Adhesive
      • 13.2.2.1. Single Layer
      • 13.2.2.2. Multilayer
    • 13.2.3. Microneedle
    • 13.2.4. Matrix
    • 13.2.5. Others (Vapor, etc.)
  • 13.3. Market Value Forecast By Application, 2017 - 2031
    • 13.3.1. Pain Management
    • 13.3.2. Hormonal Disorders
    • 13.3.3. Smoking Reduction and Cessation Aid
    • 13.3.4. Neurological Disorders
    • 13.3.5. Cardiovascular Disorders
    • 13.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
  • 13.4. Market Value Forecast By Sales Type, 2017 - 2031
    • 13.4.1. Prescription
    • 13.4.2. Over-the-Counter (OTC)
  • 13.5. Market Value Forecast By Distribution Channel, 2017 - 2031
    • 13.5.1. Hospital Pharmacies
    • 13.5.2. Retail Pharmacies
    • 13.5.3. Online Pharmacies
  • 13.6. Market Value Forecast By Country, 2017 - 2031
    • 13.6.1. Japan
    • 13.6.2. China
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Application
    • 13.7.3. By Sales Type
    • 13.7.4. By Distribution Channel
    • 13.7.5. By Country

14. Latin America Transdermal Skin Patches Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product Type, 2017 - 2031
    • 14.2.1. Reservoir
    • 14.2.2. Drug-in-Adhesive
      • 14.2.2.1. Single Layer
      • 14.2.2.2. Multilayer
    • 14.2.3. Microneedle
    • 14.2.4. Matrix
    • 14.2.5. Others (Vapor, etc.)
  • 14.3. Market Value Forecast By Application, 2017 - 2031
    • 14.3.1. Pain Management
    • 14.3.2. Hormonal Disorders
    • 14.3.3. Smoking Reduction and Cessation Aid
    • 14.3.4. Neurological Disorders
    • 14.3.5. Cardiovascular Disorders
    • 14.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
  • 14.4. Market Value Forecast By Sales Type, 2017 - 2031
    • 14.4.1. Prescription
    • 14.4.2. Over-the-Counter (OTC)
  • 14.5. Market Value Forecast By Distribution Channel, 2017 - 2031
    • 14.5.1. Hospital Pharmacies
    • 14.5.2. Retail Pharmacies
    • 14.5.3. Online Pharmacies
  • 14.6. Market Value Forecast By Country, 2017 - 2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Application
    • 14.7.3. By Sales Type
    • 14.7.4. By Distribution Channel
    • 14.7.5. By Country

15. Middle East & Africa Transdermal Skin Patches Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Product Type, 2017 - 2031
    • 15.2.1. Reservoir
    • 15.2.2. Drug-in-Adhesive
      • 15.2.2.1. Single Layer
      • 15.2.2.2. Multilayer
    • 15.2.3. Microneedle
    • 15.2.4. Matrix
    • 15.2.5. Others (Vapor, etc.)
  • 15.3. Market Value Forecast By Application, 2017 - 2031
    • 15.3.1. Pain Management
    • 15.3.2. Hormonal Disorders
    • 15.3.3. Smoking Reduction and Cessation Aid
    • 15.3.4. Neurological Disorders
    • 15.3.5. Cardiovascular Disorders
    • 15.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
  • 15.4. Market Value Forecast By Sales Type, 2017 - 2031
    • 15.4.1. Prescription
    • 15.4.2. Over-the-Counter (OTC)
  • 15.5. Market Value Forecast By Distribution Channel, 2017 - 2031
    • 15.5.1. Hospital Pharmacies
    • 15.5.2. Retail Pharmacies
    • 15.5.3. Online Pharmacies
  • 15.6. Market Value Forecast By Country, 2017 - 2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of the Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product Type
    • 15.7.2. By Application
    • 15.7.3. By Sales Type
    • 15.7.4. By Distribution Channel
    • 15.7.5. By Country

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis By Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Hisamitsu Pharmaceutical Co., Inc.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Viatris Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Nitto Denko Corporation
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Novartis AG
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Luye Pharma Group
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Teikoku Pharma
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Samyang Holdings Corporation
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Gedeon Richter PLC
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. AdhexPharma
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Sparsha Pharma International Pvt. Ltd.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview

List of Tables

  • Table 1. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
  • Table 2. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
  • Table 3. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
  • Table 4. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 5. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
  • Table 6. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
  • Table 7. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
  • Table 8. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
  • Table 9. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 10. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
  • Table 11. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
  • Table 12. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
  • Table 13. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
  • Table 14. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 15. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
  • Table 16. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
  • Table 17. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
  • Table 18. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
  • Table 19. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 20. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
  • Table 21. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
  • Table 22. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
  • Table 23. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
  • Table 24. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 25. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
  • Table 26. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
  • Table 27. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
  • Table 28. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
  • Table 29. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 30. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031

List of Figures

  • Figure 1. Global Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 2. Global Transdermal Skin Patches Market Value Share by Product Type, 2017-2031
  • Figure 3. Global Transdermal Skin Patches Market Value Share by Application, 2017-2031
  • Figure 4. Global Transdermal Skin Patches Market Value Share by Sales Type, 2017-2031
  • Figure 5. Global Transdermal Skin Patches Market Value Share by Distribution Channel, 2017-2031
  • Figure 6. Global Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 7. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Reservoir, 2017-2031
  • Figure 8. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Drug-in-Adhesive, 2017-2031
  • Figure 9. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Microneedle, 2017-2031
  • Figure 10. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Matrix, 2017-2031
  • Figure 11. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Others, 2017-2031
  • Figure 12. Global Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 13. Global Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
  • Figure 14. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Pain Management, 2017-2031
  • Figure 15. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Hormonal Disorders, 2017-2031
  • Figure 16. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Smoking Reduction and Cessation Aid, 2017-2031
  • Figure 17. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Neurological Disorders, 2017-2031
  • Figure 18. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Cardiovascular Disorders, 2017-2031
  • Figure 19. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Others, 2017-2031
  • Figure 20. Global Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
  • Figure 21. Global Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
  • Figure 22. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Prescription, 2017-2031
  • Figure 23. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Over-the-Counter (OTC), 2017-2031
  • Figure 24. Global Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2023-2031
  • Figure 25. Global Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022 and 2031
  • Figure 26. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Hospital Pharmacies, 2017-2031
  • Figure 27. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Retail Pharmacies, 2017-2031
  • Figure 28. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Online Pharmacies, 2017-2031
  • Figure 29. Global Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
  • Figure 30. Global Transdermal Skin Patches Market Value Share Analysis by Region, 2022 and 2031
  • Figure 31. Global Transdermal Skin Patches Market Attractiveness Analysis by Region, 2023-2031
  • Figure 32. North America Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 33. North America Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
  • Figure 34. North America Transdermal Skin Patches Market Attractiveness Analysis by Country, 2023-2031
  • Figure 35. North America Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 36. North America Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 37. North America Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
  • Figure 38. North America Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
  • Figure 39. North America Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
  • Figure 40. North America Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2023-2031
  • Figure 41. North America Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022 and 2031
  • Figure 42. North America Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
  • Figure 43. Europe Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 44. Europe Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
  • Figure 45. Europe Transdermal Skin Patches Market Attractiveness Analysis by Country, 2023-2031
  • Figure 46. Europe Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 47. Europe Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 48. Europe Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
  • Figure 49. Europe Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
  • Figure 50. Europe Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
  • Figure 51. Europe Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2023-2031
  • Figure 52. Europe Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022 and 2031
  • Figure 53. Europe Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
  • Figure 54. Asia Pacific Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 55. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
  • Figure 56. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Country, 2023-2031
  • Figure 57. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 58. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 59. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
  • Figure 60. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
  • Figure 61. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
  • Figure 62. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2023-2031
  • Figure 63. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022-2031
  • Figure 64. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
  • Figure 65. Latin America Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 66. Latin America Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
  • Figure 67. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Country, 2023-2031
  • Figure 68. Latin America Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 69. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 70. Latin America Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
  • Figure 71. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
  • Figure 72. Latin America Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
  • Figure 73. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2022-2031
  • Figure 74. Latin America Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022-2031
  • Figure 75. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
  • Figure 76. Middle East & Africa Transdermal Skin Patches Market Value (US$ Bn), 2017-2031
  • Figure 77. Middle East & Africa Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
  • Figure 78. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Country, 2023-2031
  • Figure 79. Middle East & Africa Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 80. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Product Type, 2023-2031
  • Figure 81. Middle East & Africa Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
  • Figure 82. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Application, 2023-2031
  • Figure 83. Middle East & Africa Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
  • Figure 84. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Sales Type, 2023-2031
  • Figure 85. Middle East & Africa Transdermal Skin Patches Market Value Share by Distribution Channel, 2022 and 2031
  • Figure 86. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Distribution Channel, 2023-2031
  • Figure 87. Company Share Analysis Transdermal Skin Patches, 2022